Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Effect of Vonafexor on Kidney Function in Subjects With Impaired Renal Function and Suspected MASH

NCT06939816 is registered in ClinicalTrials.gov with Enyo Pharma as lead sponsor.

NCT NCT06939816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06939816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Effect of Vonafexor on Kidney Function in Subjects With Impaired Renal Function and Suspected MASH
Lead sponsor
Enyo Pharma
Phase
Phase 2
Overall status
Terminated
Start date
July 1, 2025
Completion date
March 13, 2026
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage 2, chronic kidney disease stage 3, metabolic dysfunction-associated steatohepatitis